Lipella Pharmaceuticals Inc (NASDAQ:LIPO) has a beta value of 0.21 and has seen 24.24 million shares traded in the recent trading session. The company, currently valued at $3.48M, closed the recent trade at $0.43 per share which meant it gained $0.02 on the day or 6.31% during that session. The LIPO stock price is -530.23% off its 52-week high price of $2.71 and 25.58% above the 52-week low of $0.32. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.18 million shares traded. The 3-month trading volume is 3.59 million shares.
Lipella Pharmaceuticals Inc (NASDAQ:LIPO) trade information
Sporting 6.31% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the LIPO stock price touched $0.43 or saw a rise of 11.01%. Year-to-date, Lipella Pharmaceuticals Inc shares have moved -57.40%, while the 5-day performance has seen it change 6.36%. Over the past 30 days, the shares of Lipella Pharmaceuticals Inc (NASDAQ:LIPO) have changed 1.52%. Short interest in the company has seen 0.18 million shares shorted with days to cover at 0.21.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wall Street analysts have a consensus price target for the stock at $2, which means that the shares’ value could jump 78.5% from the levels at last check today. The projected low price target is $2.0 while the price target rests at a high of $2.0. In that case, then, we find that the latest price level in today’s session is -365.12% off the targeted high while a plunge would see the stock gain -365.12% from the levels at last check today.
Lipella Pharmaceuticals Inc (LIPO) estimates and forecasts
The company’s shares have lost -42.92% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -189.86% over the past 5 years.
LIPO Dividends
Lipella Pharmaceuticals Inc is expected to release its next earnings report on 2024-Aug-13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Lipella Pharmaceuticals Inc (NASDAQ:LIPO)’s Major holders
Insiders own 35.49% of the company shares, while shares held by institutions stand at 7.87% with a share float percentage of 12.21%. Investors are also buoyed by the number of investors in a company, with Lipella Pharmaceuticals Inc having a total of 7.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. As of Jun 30, 2024, the former fund manager holds about 0.43% shares in the company for having 34.52 shares of worth $15116.0 while later fund manager owns 24.91 shares of worth $10910.0 as of Aug 31, 2024, which makes it owner of about 0.31% of company’s outstanding stock.
